Introduction
Health systems, healthcare and health policy are different in every country. Each nation's health system has been shaped by a number of influences including cultural norms, politics and history. Despite the diverse patient populations and structural differences which exist across health systems, most countries share common health system goals and face similar challenges. Most health systems aim to improve patient health, be responsive to patient needs and at the same time ensure financial sustainability (WHO, 2000) . At the same time, most health systems also face common challenges, such as demographic change and escalating costs.
International comparisons provide vast potential for within and cross country learning; by offering a way to explore different approaches countries take to address similar problems to achieve comparable objectives (Nolte et al., 2006) .
Health system performance can exert a major influence on national policymakers, but neither the bald presentation of league tables nor a detailed narrative of caveats is likely to guide them towards appropriate responses. The improvements themselves will take more work at the national level for policy-makers to understand characteristics and processes that contribute to relative levels of performance. While the response to the World Health Report 2000 was an indication of the potential power of such comparisons, it also highlighted the limitations of health system comparisons, such as lack of comparable data and underdeveloped methodologies of comparison (Murray and Evans, 2003) . Although the science of comparison is advancing rapidly, there still remains great potential for misinterpretation and abuse of comparative information.
Yet, International comparisons are without question an important potential driver of health system improvement. Measurement is central to securing accountability for health system actions and outcomes to citizens, patients and payers Papanicolas and Smith, 2013; Smith et al., 2010) . At the European level another major driver behind increased demand for comparisons is the discussion and recent approval of the healthcare legislation aimed at making cross-border healthcare for European Union (EU) citizens possible (Legido-Quigley et al., 2011) .
This focus on assessment coincides with the enormous increase in the capacity for measurement and analysis of the last decade, driven in no small part by massive changes in information technology and associated advances in measurement methodology. Various recent ongoing initiatives and developments have the potential to add further value to international comparisons, such as the further development of electronic health records and data linkage, which may greatly improve data collection and coordination at the system level.
This chapter seeks to summarize the current state of international health system comparisons by highlighting the key achievements that have been made in data collection and methodological issues as well as outlining the key challenges and priorities for future work. In particular, the chapter will consider what performance domains are compared, the development of data sources and measurement instruments across these domains, and what the analytic methodologies are used to assess international evidence on performance. It will conclude by presenting key lessons and future priorities that policy-makers should take into account.
How to conceptualize a comparison?
A theoretical framework is necessary to assist organizations in defining a set of measures that reflect key objectives and in turn allow for an appropriate assessment of their performance (Murray and Evans, 2003; Papanicolas, 2013) . In their review of health system frameworks, Hsiao and Sidat (2008) propose a threefold classification of frameworks. The first type of framework they outline is a 'descriptive framework'. This type of framework provides a basic description of the health system and the components it is made up of, yet does not explain why any particular health system would perform better than another; one example is the European Observatory on Health Systems and Policies' Health Systems in Transition (HiT) country profiles which provide detailed descriptions of each European healthcare system including reform and policy incentives (http://www.euro.who.int/en/aboutus/partners/observatory/health-systems-in-transition-hit-series). As health systems differ considerably with regards to their organization, structure and design, this type of framework can be particularly useful in order to understand the various features of the health system that may influence differential levels of performance attainment.
The next type of framework is and 'analytical functional framework'. This type of framework goes beyond describing what exists in a health system to also analyzing the functional components of a system. This offers a more holistic and deeper analysis of health systems than the purely descriptive frameworks, but does not reveal the effectiveness of particular policies, reforms or interventions. For example, the WHO 2000 health system framework identifies both the health system objectives and the functions of the health system which will influence the attainment of these goals (Murray and Frenk, 2000) . the policy maker to make better resource allocation decisions, through the rigorous and systematic collection of information to determine the value of a given health service.
The choice of a useful type of framework depends on the purpose of the performance evaluation. For example, at the systems level an M&E framework may not be feasible given the number of complex relationships that contribute to the attainment of particular objectives. In this case, a descriptive or an analytic framework may be more informative, while an M&E framework may still provide necessary insight as to whether a particular policy or intervention is producing the desired results.
Where are we now?
As outlined by the WHO (2000) , international organizations, such as the WHO, the OECD, and the EU play an important role in facilitating the comparisons of health systems and their own efforts at national performance assessment. These organizations produce global norms, standards and guidance. Thus many of the international benchmarking exercises undertaken are based on conceptual frameworks constructed and populated using comparative data at produced by, or funded by, these organizations. Despite existing differences in key objectives and priorities at the national levels, it is possible these international efforts identify the broad areas of health system performance that are valued and compared internationally (Table 8 .1). Quality is often difficult to define as it includes a number of different dimensions.
While efficiency is difficult to conceptualize because it refers to the degree of performance attained relative to what is attainable given resources which presupposes a good understanding of all other performance domains. Many international frameworks will reconcile these concepts by identifying quality is seen as the attainment of high absolute levels in the main objectives, equity as the distribution of these goals across the population, and efficiency as the level of overall performance relative to what is attainable (Hurst and Jee-Hughes, 2001; Murray and Frenk, 2000) .
However, given the complicated and multi-faced nature of these dimensions, it becomes extremely challenging to identify suitable metrics. As a result, measures corresponding to these domains tend be fragmentary metrics. For example, quality is often measured by specific health service outcomes or levels of attainment of best-practice clinical practices, while efficiency is often captured by unit costs of individual services.
Development of metrics in key performance domains
The range and content of available performance data vary considerably between countries. International organizations such as the OECD and the WHO attempt to report on a range of indicators in each of the domains (Table 8 .1), but are also constrained by available data in their member states. Countries will focus different degrees of effort at collecting new information to fill existing data gaps, as opposed to using the information that is readily available or out of date.
Population health
The ultimate goal of any health system is to improve the health of its population.
Thus it follows, that some of the most common comparisons of health systems use population health data to consider the trends and variations in aggregated health. In the past decades major progress has been made in population health indicators, and particularly with regards to their ability to capture: (1) variations in morbidity as well as mortality; and (2) the contribution of healthcare to health.
The main indicators used to make cross country comparisons in population health capture the aggregate mortality experience across populations, such as life expectancy infant mortality and age-standardized mortality. One of the great advantages of these indicators is the availability of data and ease of calculation which permits comparisons across many different countries. However, while these trends can summarize the total mortality experience across a given population over a particular time period, they do indicate the contribution of healthcare to health status, particularly if there is an absence of data on cost of death (Karanikolos et al., 2013; Nolte et al., 2010) .
Age standardized mortality rates by cause can more informative about particular trends in the burden of illness. Where mortality rates are more sensitive to the quality of medical care these indicators are also better able to assess the contribution of the health system. For example particular age/disease specific indicators -such as neonatal mortality, ischemic heart disease mortality, or HIV mortality are often considered better indicators of health system performance. While age-standardized mortality rates by cause are easy to calculation and reliable data is available for most high and middle income countries, these are indicators are more susceptible to recording and reporting practices. For example, in some instances coding of cases differs considerably across countries, such as for perinatal mortality, and can account for huge apparent differences in mortality. Even where coding is standardized, such as through the International Classification of Disease (ICD) system, changes over time and variations in interpretation across countries may have effects on apparent trends (Fahy, 2013) . For example, there may be an apparent shift when a new code is introduced, or when a country switches to a new version of a code.
In some cases, data are available on incidence and mortality, such as cancer. In these instances it is possible to calculate disease-specific survival -which indicates the average length of time that individual survive following diagnosis. While crosscountry comparisons of survival rates can be very influential, and thought to reflect variations in quality of care across countries, there are a number of issues that need to be taken into account when attempting to draw conclusions from them. The first is the sampling of the populations included in the analysis, which may differ across countries and/or influenced by the availability data linkage systems across countries;
for example countries with better linkage systems may have shorter survival rates as more cases are reported at time of death (Coleman et al., 2008) .
Interpretations of differences of cross country rates should also be approached with caution, given variations in national approaches to diagnosis and treatment.
Countries with extensive screening activities in place will detect more cases earlierbut if this is not attached to significant survival benefit (as for prostate cancer) survival rates will seem artificially longer (Karanikolos et al., 2013) .
One of the key limitations to the indicators discussed above is that their focus is on population mortality rather than population health. The past 20 years have seen major efforts in the measurement of morbidity, and summary measures that are able to provide more information on the total health experience. It is not uncommon for household surveys to measure and report on self-reported health status and diseasespecific measures. Summary measures such as health adjusted life expectancy (HALE) and DALYs are able to report on the combined mortality and disability in the population. These require measurements on the incidence and relative valuation of disability states.
More recent research in the area of population health has focused identifying metrics which are able to better measure the contribution of health services to improved health. This has led to the development of concepts such as avoidable mortality that refers to deaths that are considered avoidable in the presence of appropriate and timely medical care or preventable by population-based interventions (Nolte and McKee, 2004) . This involves reviewing the clinical literature to identify a list of conditions that is amenable to healthcare and then measure the deaths occurring in these conditions. While this indicator is able to provide more insight into the performance of the health system it does suffer from some notable limitations related to measurement and interpretation. Its aggregated nature may disguise what is driving the overall figure, as well as important variations within countries. Moreover, it does not take into account the dynamic nature of the health system -that is the lag that can occur between treatment and effect. Finally, this indicator needs constant updating to reflect changes in medical practice and technology.
Health service outcomes and processes
Many international comparisons of health system performance are interested in the value added by different health services, or health service outcomes. Currently the majority of internationally comparable data in this area is related to mortality outcomes in acute care. Yet, given the increasing incidence of mental illness, chronic conditions and multiple co-morbidities across the world more emphasis needs to be put on the development of a richer set of indicators that are able to capture morbidity outcomes as well as performance across different health service settings including primary care, long-term care and mental illness (Klazinga and Li, 2013) .
Although clinical outcome measures are the gold standard for measuring health service outcomes in healthcare, their use can be problematic, for example if the outcomes cannot realistically be assessed in a timely or feasible fashion, or when trying to understand the contribution of health services to health outcomes. Many indicators will thus focusing on mortality rates associated with procedures where the quality of care is known to have a large impact on patient outcomes, such as those that are heavily dependent on technical skill. Popular outcome indicators of this sort are 30-day mortality rates for acute myocardial infarction (AMI) and Stroke.
Another way to assess quality directly related to health service performance is through process measures. Process measures have certain distinct advantages, for example, they are quicker to measure, and easier to attribute directly to health service efforts. However, process measures may ultimately ignore the effectiveness or appropriateness of the intervention and pre-judge the nature of the response to a health problem, which may not be identical in all settings, such as for patients who have multiple morbidities. To avoid this they should be measured with appropriate exclusion criteria, and to make them more meaningful to patients and policy-makers it is best to report them as related to outcomes. 
Patient experience, responsiveness and satisfaction
System performance measures related to patient and population expectations of non-health enhancing aspects of the health system are also increasingly gaining interest since a decade or so. Here, a range of non-clinical factors are considered, such as service availability, patient choice and how the system respects patient dignity, autonomy and confidentiality. One major challenge is the use of different concepts, whereas three different terms are most popular: satisfaction, experience and responsiveness (Busse, 2013) .
Relevant data to measure the performance of health systems in these areas are collected by surveys of patients or the general population (Valentine et al., 2010) .
Amongst patients, satisfaction scores typically represent attitudes to care or aspects of care, while among the general population, satisfaction metrics capture broader attitudes towards the health system. Measures of satisfaction vary considerably in two particular respects: the group whose satisfaction is measured, and the type of satisfaction.
Metrics in this area are sensitive to a multitude of factors. For instance, systematic reviews report that socio-demographic characteristics and health service delivery characteristics may impact in reported satisfaction and create bias. Yet the strength and direction of the relationships between satisfaction and socio-economic categories are not consistent (Bleich et al., 2009; Papanicolas et al., 2013) . Similarly, studies find that patient satisfaction may not be highly correlated with health outcomes or the technical quality of care provided. Rather, patients have been influenced by the manner and means of the processes of healthcare delivery, such as having a choice of provider or a good patient-practitioner relationship (Crow et al., 2006) . Survey design issues, such as scaling and wording, are also likely to create variations in responses.
In a review of international data on satisfaction, Busse (2013) identifies three factors that may influence survey responses: (1) the context in which a survey takes place, (2) the ability for respondents to differentiate between the system as a whole and certain subsectors about which the respondent may be especially knowledgeable, and (3) the inability to differentiate between the healthcare system and government in general. These factors may apply across both individuals and countries, and a lack of universally accepted terminology may further complicate the development of comparable metrics.
Furthermore, expectations concerning health system performance, on which individual satisfaction levels are inherently based, are likely to vary across both patients and populations. Respondents with lower expectations may report higher satisfaction with unsatisfactory care and vice versa. This bias has prompted many researchers to explore respondents' experiences of care in addition to more subjective attitudinal questions (Jenkinson et al., 2002) . A growing body of international metrics of this sort is now available for a subset of countries (such as those covered by the Commonwealth Fund and the OECD).
Equity and financial protection
The principle of equity in health addresses the distribution of performance objectives Here, international comparisons reveal that inequities in health status related to socio-economic factors exist in most countries, but the reasons may be different.
With regard to procedural equity, different financing mechanisms (such as user fees, and co-payments) and organizational structures have been linked to differences in access to healthcare services (Hernandez-Quevedo and Papanicolas, 2013) .
A number of different tools are used to assess procedural and substantive equity and to compare the performance across countries (Table 8. 2). Typically, the use of these tools requires information on the outcome of interest linked to socio-economic variables in order to study the distribution across populations of interest. Large improvements in international comparisons of equity, both substantive and procedural, can be made through improvements in availability and quality of population health and health service outcome data.
Most notably, efforts to link various databases and to provide more detailed longitudinal data will allow researchers and policy-makers to better assess, how factors within and outside the health system influence equity, whether they persist over time, and how they are influenced by policy changes within or outside the healthcare system. Limited by the availability of outcome indicators and the linkage to socioeconomic variables; surveys may include outcome and socio-economic information, but subjective measures of health status raise methodological problems; longitudinal data are lacking; objective measures such as physicians' assessments or hospital stays are best for comparative purposes, but availability is limited; biomarker may be biased, are not included in longitudinal data, and are often not standardized across countries.
Procedural equity indicators
Equity in access or utilization unmet need, use-needs ratios, odds ratios, horizontal index
Utilization is not equivalent to access, but terms are often used indistinctively, implying that an individual's use of health services is proof that he/she can access these services; utilization and need are often captured by survey information, which can suffer from reporting bias as well as comparability issues across countries; little data is collected longitudinally, and there are large gaps on data to inform on environmental factors.
Financial protection indicators
Catastrophic and impoverishing health payments; out-of-pocket payments Limited insights into major determinants of inadequate financial protection in a given context; do not inform on relationships between financial barriers to access and the level of financial protection, and individuals at risk; lack of research into complex factors affecting access to health services as determinants of financial protection levels does not allow for reliable conclusions; cross-country examinations of the relative importance of out-ofpocket expenses for funding the health system can convey helpful insights for performance comparisons of financial risk; comparing the extent of financial protection requires micro-data related to households' out-of-pocket health expenses to some metric in terms of their living standards.
Source: authors' own table, adapted from Hernandez-Quevedo and Papanicolas, 2013; Moreno-Serra et al., 2013; Papanicolas and Smith, 2013. Financial protection is often studied separately from equity and looks specifically at the extent to which people are protected from the financial consequences of ill-health and the use of medical care (Moreno-Serra et al., 2013) . Here, useful measurement tools have been developed to assist policy-makers, comprising indicators related to out-of-pocket payments made to healthcare either as a percent of total expenditures or related to some income threshold.
Productivity and efficiency
There are perhaps no performance indicators that receive more attention than the related concepts of productivity and efficiency. The notion of health system productivity and efficiency is in essence quite simple: they both attempt to measure how much valued output (such as health or responsiveness) is produced relative to associated inputs, but efficiency also considers this in relation to the maximum output that could be produced (Papanicolas and Smith, 2014) .
Furthermore, economists often differentiate between two types, namely allocative efficiency and technical efficiency. Allocative efficiency indicates the extent to which limited funds are directed towards producing the correct mix of healthcare inputs, such as health services, in line with the preferences of payers. Technical efficiency indicates the extent to which a provider is securing the minimum costs or the maximum quantity of outputs, regardless of the value placed on those outputs.
International comparisons of health system efficiency offer great potential for stakeholders to compare different system's value for money and create incentives for knowledge exchange and policy-learning. However, conceptual and methodological complexities place these useful performance indicators among the most difficult to estimate. While health system efficiency is probably the most desirable efficiency metric for policy-makers, comparable efficient and productivity metrics can be constructed to evaluate any segment of the health production process, including the number of surgical procedures per physician (i.e. physical inputs to activities) or the additional years of life associated with spending on health (i.e. cost to outcome).
These metrics are also extremely useful for informing national policy and fostering meaningful comparisons within and across country settings.
The most desirable measure of efficiency in the health sector is one that captures the full production process, from health expenditures to health outcomes (Hollingsworth, 2003) . Satisfactory measurement of whole system efficiency therefore relies on many issues in individual performance domains. For this reason, there is a need for a more feasible and useful strategy to examine efficiency by scrutinizing the operation of specific parts of the health system, or whole system efficiency for the treatment of particular cases. An example of the first approach is the measurement and comparison of indicators, such as the average 'length of in-patient stay' that are collected in many settings over a long period.
On national level, cost per quality-adjusted life year (QALY) of an intervention is a common indicator to capture the full production process but for an adjusted case. An intervention is technically efficient, if it provides a maximum number of QALYs at a given level of spending, while a healthcare purchaser would be efficient in allocation resources, if they pay for an optimal mix of interventions that maximizes population health. The QALY indicator is not without problems. Measures of the full production process are often elusive for many areas of the health system, due to the problems to observe and quantify health outcomes (Busse et al., 2008; Street et al., 2010) .
One response to the problems is the use of statistical or non-parametric tools to estimate a production possibilities frontier, and use this to compare the efficiency of health systems (Joumard, 2010; WHO, 2000) or health system organizations. Typical approaches include stochastic frontier analysis or data envelopment analysis, both of which use information on the observed behaviour of all organizations to infer the maximum feasible level of attainment (the production function) and to offer estimates of the extent to which each individual organization falls short of that optimum. The methods take radically different approaches and are technically challenging; consequently, while being conceptually appealing, there are few examples of such methods being used by decision-makers.
Conclusion
Individual nations are increasingly introducing more systematic methods for health system performance assessment, including benchmarking activities with other countries. These developments have significantly improved and fostered crosscountry comparison. There is now wide consensus around the identification of key performance domains that should be compared, and the degree of comparability and availability of international health data in these areas has also improved. At the same time, many challenges persist and call for further investigations in this area.
Comparisons need to be conducted with properly validated measures, metrics must be widely accepted and defined in unambiguous terms that are consistent with most countries' data collection systems, and users should be familiar with limitations in existing indicators. 
Summary
 International comparisons allow for within and cross-country learning, and may serve as drivers of healthcare system improvement.
 Comparisons need to be conducted with properly validated measures.
 Metrics must be widely accepted and defined in unambiguous terms that are consistent with most countries' data collection systems; and users should be familiar with limitations in existing indicators.
 Development of performance indicators for different domains has made significant progress and will be furthermore fostered by new technologies, but still many challenges and constrains of comparison remain to be solved.
